Jeffrey J. Brown - 25 Jun 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
25 Jun 2025
Net transactions value
+$126,528
Form type
4
Filing time
26 Jun 2025, 19:02:59 UTC
Previous filing
07 May 2025
Next filing
01 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BROWN JEFFREY J Director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE /s/ Jason L. Groves, attorney-in-fact 26 Jun 2025 0001245377

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $0 +11,168 +62% $0.000000 29,128 25 Jun 2025 Direct F1
transaction MED Common Stock Award $126,528 +9,449 +32% $13.39 38,578 25 Jun 2025 Direct F2, F3
holding MED Common Stock 4,233 25 Jun 2025 Jeffrey Brown Living Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.
F2 The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
F3 The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.
F4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.